Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GPSI .007 +16%
you must have ESP because when you PM'D me i was already checking out this board (lol). i don't know what caused today's volume, but i was holding some shares and then i saw this come to life. maybe tomorrow she runs just for the heck of it. this is my last post of the day, GLTA.
SPOC .0025 had a nice pop recently and it's getting a little action today
yw. i looked at a chart and this has gone up real nicely. wow!
glta
UCPC .002 big volume coming in
UCPC .002 big volume coming in
from last week:
Optical Systems, Inc. Acquires Automotive Software Designers, Inc.
Friday, November 16 2007 - 12:19
OPSY $0.33 $0.06 (%22.22)
HOUSTON, TX -- (MARKET WIRE) -- 11/16/07 -- Optical Systems, Inc. (PINKSHEETS: OPSY) announced the acquisition of Automotive Software Designers, Inc., a private company founded by B.J. Grisaffi, a veteran of more than 30 years in general management of automobile dealerships. Mr. Grisaffi developed the premiere auto dealer customer sales information system, the "Save-a-Deal" program. "Save-a-Deal" simplifies and personalizes the customer car buying experience, significantly increasing dealer profits by automating workflow within a dealership, eliminating manual forms, and dramatically reducing the time to desk and finance a deal. For information, dealer testimonials, and a list of clients see www.saveadeal.net
SAFE HARBOR STATEMENT
Safe Harbor Statement under the Private Securities litigation Reform Act of 1995: The statements, other than the statements of historical facts, may be deemed to contain forward-looking statements with respect to events, the occurrence of which involves risk and uncertainties, including, without limitation, demand and competition for the company's products and services, the availability to the company of adequate financing to support its anticipated activities, the ability of the company to generate cash flow from operations and the ability of the company to manage its operations. As statements regarding future events concern management's estimates of future results of operations, and as these estimates are based on many elements beyond management's control, differences from management's estimates may occur, and such difference may be material.
Although Optical Systems, Inc. believes the assumptions underlying the forward-looking statements contained herein are reasonable, any assumption could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion should not be regarded as a representation by Optical Systems, Inc. or any other person that the objective and plans of Optical Systems, Inc. will be achieved.
Contact Info:
Investor Relations
B.J. Grisaffi
713-467-1987
UCPC .002 getting some action
UCPC .002 getting some action
yes. funny how 15,000 shares cleared out the .01's
could get crazy after .01
sounds good to me :) hardly any shares
DATV .005 volume coming in
GPSI .006 +33% .0055 X .006
Skin cells made to mimic stem cells
Scientists say method could ease ethical debate, open new era in medicine
By Alan Boyle
Science editor
MSNBC
updated 39 minutes ago
Alan Boyle
Science editor
Two research groups have found different genetic recipes to give ordinary skin cells the power to turn into virtually any kind of human tissue, just as embryonic stem cells do.
If the recipes live up to their promise, they could someday end the ethical debate over embryonic stem cell research — and usher in an era when a person's own cells could be manipulated to mend a broken spinal cord, heal a damaged heart or regenerate other failing tissues.
But in their current state, the recipes are too risky for disease treatment, and even the scientists behind the latest studies cautioned that therapies are still years away. In announcing their discoveries, they emphasized that much more research still needs to be done on stem cells that have been derived from human embryos.
Story continues below ↓
--------------------------------------------------------------------------------
advertisement
--------------------------------------------------------------------------------
"It's not the time to say human embryonic stem cell research is dead," James Thomson, a biologist at the University of Wisconsin in Madison, who is behind a study appearing in the journal Science, told msnbc.com.
Kyoto University's Shinya Yamanaka, the principal author of a study published by the journal Cell, echoed that view, saying it would be "premature" to conclude that the cells created in his lab could replace embryonic stem cells.
The two sets of findings are already stirring up fresh controversy among scientists.
Edinburgh University's Ian Wilmut — who led the research that gave rise to Dolly, the first cloned sheep, a decade ago — has been quoted as saying he's abandoning his cloning efforts to adopt the new approach. But another stem cell pioneer, Advanced Cell Technology's Robert Lanza, said he was alarmed at Wilmut's statement and worried that the new studies would drown out other stem cell research like a "tidal wave."
"This work represents a tremendous scientific milestone, the biological equivalent of the Wright brothers' first airplane," Lanza, ACT's chief scientific officer, told msnbc.com. "It's a bit like turning lead into gold. But this is not over by a long shot. It's extremely important to temper this announcement with caution."
Lanza said he would continue his work on a technique to extract stem cells from human embryos without destroying the embryo itself.
No embryos required
The recipes detailed in Cell and Science don't require embryos at all — or even unfertilized human egg cells. Instead, the technique involves slipping a set of four genes into skin cells, in a specially prepared culture that coaxes the cells to behave like an embryonic stem cell.
Like embryonic stem cells, these reprogrammed cells become "pluripotent" — that is, they're capable of turning themselves into virtually any tissue type in the human body, including neurons and heart tissue. They also exhibit many of the other biochemical properties of embryonic stem cells, although they're not genetically identical to stem cells.
Yamanaka's research builds on previous work that he and his colleagues conducted with mice. They used the same four genes that made mouse cells pluripotent — Oct3/4, Sox2, c-Myc and Klf4 — but found that they had to adjust the culture to suit human cells rather than mouse cells.
GPSI .005 .005 x .0055
GPSI .0045 .0045 x .005
GPSI .004 .004 x .0045 volume coming in
now .004's
FRTW .18
FRTW .163 bouncing off low of .11 from last week. volume coming in
and good luck to you :)
thnx prado. GM
MIDX .005 .005 x .01
HOST .008 .007 x .008 5M OS looks cheap here IMO grabbed a small piece
ANWK .04 +344% .02 x .04
locked and loaded here!! :)
PPYR .005 .01 x .02 showing some activity. it's a shell flying under the radar. from the pinksheets:
PPYR — PrimePlayer Incorporated
Com ($0.001)
Primary Venue: Pink Sheets
QuoteNewsChartsCompany InfoFilingsShort InterestInsider TransactionsInside Quote Best Bid Best Ask Time of Last Inside Change
0.01 (5000 shares) 0.03 (5000 shares) 11:38 AM
Trade Data / Last Trade 11:46 AM Last Sale 0.01 Change -0.02
% Change -66.6667 Tick Down
Daily High 0.03 Daily Low 0.01
Opening Price 0.03 Volume 82,200
Disclosure Category
No Information
Primary SIC — Industry Classification
3911 - Jewelry, precious metal
State Of Incorporation
NV
Jurisdiction Of Incorporation
USA
SEC Reporting Status
SEC Reporting Company
CIK
0001119272
Fiscal Year End
12/31
Estimated Market Cap
600,114.21 as of Nov 15, 2007
Outstanding Shares
20,003,807 as of Jun 9, 2006
Number of Share Holders of Record
62 as of Jul 19, 2006
Company Notes
Last known address (7/6/2007): 2235 E. Flamingo Road Suite D-4, Las Vegas, NV 89119-0808
Formerly=Foxy Jewelry, Inc. until 12-02
MIDX .005 .004 x .005
GTLL .0115 +60%
GTLL .0115 +60% MEUSE shell moving
GTLL .009 .009 x .0115 MEUSE shell getting some nibbles
GTLL .009 .009 x .0115 MEUSE shell getting some nibbles
keep us posted . thank you
anybody know if MA is officially the director now?
best wishes for your new addition! :)
have you looked at 53chevy's shell list? he has a list of shells he comprises each month and he updates it frequently.
that will give you AS/OS info as a start. i own GTLL myself and would of course like to see something happen here.
PBLS .0024
GTLL .009 MEUSE shell upticked volume coming in
GTLL .008 .008 x .009 meuse shell upticked on tiny volume
volume coming in!!